D.A. Davidson & Co. Emergent Bio Solutions Inc. Transaction History

D.A. Davidson & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $176,859 - $242,608	-3,667 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$55.63 - $73.24 $14,408 - $18,969	259 Added 7.6%	3,667 $217,000
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $177,386 - $226,666	3,408 New	3,408 $224,000
Q2 2018 Aug 02, 2018	SELL	$48.33 - $55.64 $195,639 - $225,230	-4,048 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$44.44 - $54.39 $179,893 - $220,170	4,048 New	4,048 $213,000
Q3 2017 Nov 08, 2017	SELL	$34.14 - $40.45 $40,968 - $48,540	-1,200 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	1,200	1,200 $0

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $412M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.